Clinical Report: Downregulation of Complement Receptor 2 in S. aureus Sepsis
Overview
This study identifies complement receptor 2 (CR2) downregulation in Staphylococcus aureus sepsis. In both murine models and human patients, decreased CR2 levels correlated with increased mortality and disease severity.
Background
Sepsis remains a leading cause of mortality globally, particularly due to Staphylococcus aureus infections. Understanding the role of immune dysregulation in sepsis can aid in developing targeted treatment strategies.
Data Highlights
No numerical data or trial data provided in the source material.
Key Findings
CR2 downregulation was significantly observed in deceased patients compared to survivors and healthy controls.
The extent of CR2 downregulation correlated with the administered dose of S. aureus in murine models.
Progressive B-cell depletion and CR2 downregulation were noted in infected mice, correlating with disease severity.
CR2 downregulation was independent of complement factor 3, TLR2, and TNF-α.
CR2 expression loss may indicate B-cell activation and differentiation during severe infections.
Antibiotic treatment in infected mice restored CR2 levels.
Clinical Implications
Further validation of CR2 as a biomarker in larger clinical cohorts is warranted.
Conclusion
CR2 downregulation is associated with severe infection and mortality in S. aureus sepsis.
by Pradeep Kumar Kopparapu, Meghshree Deshmukh, Santhilal Subhash, Majd Mohammad, Zhicheng Hu, Anders Jarneborn, Muhammad Arif, Marcela Pekna, Lars Ljungström, Gunnar Jacobsson, Ola Grimsholm, Tao Jin
